Season 9, Episode 52
We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are cured.
To find out more, check out the podcasts from which this hour was drawn: “Will a Covid-19 Vaccine Change the Future of Medical Research?”